Company Analysis

Rallybio Corporation (RLYB)

Nasdaq: RLYB · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2018
Grade5.3
◀ Past 5.1● Present 5.5▶ Future 5.2
4 est.

Who runs Rallybio Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Uden Stephen
Chief Executive Officer. First filing Jul 2021, latest Oct 29, 2026, 1 filing in all.
Officers reporting now
3
of 10 people with a filing in the last fifteen months
Directors reporting now
7
15 people on the record since 2021
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Mackay MartinExecutive ChairmanJul 2021Nov 5, 2026none
Lieber Jonathan IChief Financial OfficerFeb 2023Nov 3, 20262 · $0.00
Uden StephenChief Executive OfficerJul 2021Oct 29, 2026none
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hunt RonalddirectorJul 2021Nov 5, 2026none
Nash Christine AdirectorApr 2022Oct 30, 2026none
Chung WendydirectorAug 2022Oct 28, 2026none
Boudreau Helen MdirectorJul 2021Oct 20, 2026none
Soteropoulos PauladirectorJul 2021Oct 20, 2026none
Hopfner Robert LornedirectorJul 2021Oct 14, 2026none
Liu HuidirectorApr 2022Sep 28, 2026none
Owners of more than 10% of a classsales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Adar1 Capital Management, LLC10% ownerMay 2026May 20, 2026none
Schneeberger Daniel10% ownerMay 2026May 20, 2026none
Fmr LLC10% ownerJul 2021Mar 10, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton RLYB · research, not advice